Lincosamideantibiotic.Inhibitsproteinsynthesisbybindingtothe50Sribosomalsubunitandpreventingearlypeptidechainelongationinbacteria.
SoldforresearchpurposesunderagreementfromPfizerInc.
M.Wt | 461.44 |
Formula | C18H33ClN2O5S.HCl |
Storage | Storeat-20°C |
Purity | ≥98%(HPLC) |
CASNumber | 21462-39-5 |
PubChemID | 16051951 |
InChIKey | AUODDLQVRAJAJM-XJQDNNTCSA-N |
Smiles | CN1[C@H]([C@@](N[C@@]([H])([C@@]2([H])O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](Cl)C)=O)C[C@@H](CCC)C1.Cl |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Solvent | MaxConc.mg/mL | MaxConc.mM | |
---|---|---|---|
Solubility | |||
DMSO | 46.14 | 100 |
Thefollowingdataisbasedontheproductmolecularweight461.44.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
---|---|---|---|
1mM | 2.17mL | 10.84mL | 21.67mL |
5mM | 0.43mL | 2.17mL | 4.33mL |
10mM | 0.22mL | 1.08mL | 2.17mL |
50mM | 0.04mL | 0.22mL | 0.43mL |